Sorting by

×

Biotech

Emerging Managers Podcast: Investing In The Realms Of Biotech

This week on the Emerging Managers Podcast: Investing In The Realm Of Biotech With Junaid Mian, RPh of 1435 Capital Management Watch and listen to the podcast here: https://emergingmanagerspodcast.com/investing-in-the-realm-of-biotech-with-junaid-mian-of-1435-capital Brought to you by Black Dog Venture Partners, VC Fast Pitch and Podetize (Brandcasters, Inc.) Your hosts: Scott Kelly and Tracy Hazzard

Emerging Managers Podcast: Investing In The Realms Of Biotech Read More »

BioTech x Aging NYC: Building, Partnering, Investing

Tonight, Junaid Mian, RPh will be Moderating a panel on “Strategic Capital for Early Stage Biotechs Tackling Aging” at Daniel Dacey‘s event Biotech x Aging NYC: Building, Partnering, Investing with panelists Christopher R. Shepard, Greg Kubin, and Dylan V. Livingston. ​This event will bring together scientists, startup operators, pharma professionals, and investors who are tackling

BioTech x Aging NYC: Building, Partnering, Investing Read More »

Aging Code Summit 2025

1435 Capital is thrilled to be part of the upcoming Aging Code Summit, taking place June 11th in Cambridge and June 12th in Boston. This premier event brings together leading scientists, biotech entrepreneurs, investors, and industry pioneers to explore how AI is transforming the future of longevity science and healthspan extension. We’re especially proud to

Aging Code Summit 2025 Read More »

How Regenerative Medicine Could Revolutionize Aging: Insights from the HealthSpan Compass Podcast

Junaid Mian, Venture Partner at 1435 Capital and a leader in healthspan innovation, launched the inaugural episode of the HealthSpan Compass podcast under the Healthspan Action Coalition. This groundbreaking episode explored how regenerative medicine could reshape aging, why healthcare should prioritize disease prevention, and how aging well can become a global priority. Key Themes from Episode 1

How Regenerative Medicine Could Revolutionize Aging: Insights from the HealthSpan Compass Podcast Read More »

1435 Capital Management: Strategic Investments for 2025 and Beyond

As we enter 2025, the IPO market is poised for a significant rebound, supported by favorable macroeconomic conditions, regulatory reforms, and sectoral growth trends. At 1435 Capital Management, we are sharpening our focus on transformative industries that align with the future of innovation and economic expansion. Our investment strategy for 2025 includes increased allocations to space

1435 Capital Management: Strategic Investments for 2025 and Beyond Read More »

Junaid Mian & Nach Dave on Master Your Finances

Get ready to explore the future of healthcare and innovation with Nach Dave and Junaid Mian. Nach Dave, a healthcare executive and regulatory affairs expert, brings over 23 years of experience in the pharmaceutical and medical devices industry. Known for his strategic expertise, Nach has been instrumental in supporting MedTech startups and advancing clinical and

Junaid Mian & Nach Dave on Master Your Finances Read More »

Funding the Future: Insights from NJ Bioscience Center’s Panel Discussion – October 26, 2024

ICYMI, the New Jersey Bioscience Center recently hosted a panel discussion exploring alternative funding sources for life sciences companies, and I found it incredibly insightful. The discussion focused on securing funding from non-traditional sources and addressed these key questions: * How were the next generation of drugs, diagnostics, and devices funded? * What new models

Funding the Future: Insights from NJ Bioscience Center’s Panel Discussion – October 26, 2024 Read More »